Received: 19 June 2019
Accepted: 14 November 2019
First Online: 2 December 2019
Compliance with ethical standards
: T. Bilhim is on the Advisory Board of Merit Medical, is a consultant for Terumo, a stock holder in the company “Embolx” and has a speaker agreement with Philips. M. Sapoval is a consultant for Merit Medical and has received research grants from BTG and Merit Medical. All other authors declare that they have no conflict of interest.